tm logo
TRUVESIC
FORMALIZED

on 27 Oct 2023

Last Applicant/ Owned by

CG ONCOLOGY INC.

400 Spectrum Center Dr., Suite 2040Irvine, CA 92618

US

Serial Number

2289692 filed on 27th Oct 2023

Correspondent Address

SUITE 16001 FIRST CANADIAN PLACE100 KING STREET WESTTORONTO

ONTARIO

CA

M5X1G5

TRUVESIC

Trademark usage description

pharmaceutical products, pharmaceutical preparations and biological preparations for the treatment of cancer and immunological disorders; biopharmaceu Read More

Classification Information


Class [005]
Pharmaceutical products, pharmaceutical preparations and biological preparations for the treatment of cancer and immunological disorders; Biopharmaceuticals for the treatment of cancer, namely, antibodies, non-antibody proteins, blood and blood components, stem cells, hormones, blood factors, tumor necrosis factors; Chemical preparations for medical or pharmaceutical purposes, namely, for cancer treatment, oncology and immunotherapy for auto immune diseases; Pharmaceutical products, namely, diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing


Classification kind code

12

Class [042]
Pharmaceutical research and development; Providing medical and scientific research information in the fields of oncology, autoimmune disorders; immunotherapy, immunotherapeutics, biotechnology, biopharmaceuticals, pharmaceuticals, therapies, diseases, and disorders


Classification kind code

12

Mark Details


Serial Number

2289692

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 287
on 09th Nov 2023
Pre-Assessment Letter Sent
Submitted for opposition 30
on 27th Oct 2023
Filed
Submitted for opposition 1
on 27th Oct 2023
Created
Submitted for opposition 31
on 27th Oct 2023
Formalized